Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vincent

Showing results (681-690 of 1,192) with videos related to

Pageof 120
Sort By:
European Journal of Haematology|November 11, 2014
Clinical course and prognosis of non-secretory multiple myelomaSagar S Chawla, Shaji K Kumar, Angela Dispenzieri, et al.
The American Journal of Tropical Medicine and Hygiene|August 9, 2019
Use of a Blockade-of-Binding ELISA and Microneutralization Assay to Evaluate Zika Virus Serostatus in Dengue-Endemic AreasEduardo J M Nascimento, Matthew I Bonaparte, Ping Luo, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|May 11, 2004
Characterization of the rat intestinal Fc receptor (FcRn) promoter: transcriptional regulation of FcRn gene by the Sp family of transcription factorsLingling Jiang, Jiafang Wang, R Sergio Solorzano-Vargas, et al.
Mayo Clinic Proceedings|August 4, 2009
Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patientsJohn P Bida, Robert A Kyle, Terry M Therneau, et al.
Blood Cancer Journal|June 11, 2024
Performance of newer myeloma staging systems in a contemporary, large patient cohortGhulam Rehman Mohyuddin, Samuel M Rubinstein, Shaji Kumar, et al.
The Lancet. Oncology|October 27, 2009
Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trialS Vincent Rajkumar, Susanna Jacobus, Natalie S Callander, et al.
British Journal of Haematology|December 5, 2009
Impact of dexamethasone responsiveness on long term outcome in patients with newly diagnosed multiple myelomaShirshendu Sinha, S Vincent Rajkumar, Martha Q Lacy, et al.
The Clinical Neuropsychologist|January 25, 2012
Cognitive change associated with self-reported mild traumatic brain injury sustained during the OEF/OIF conflictsTresa M Roebuck-Spencer, Andrea S Vincent, David A Twillie, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|May 1, 1996
[Modulation of the tumoral progression by anti-idiotypic antibodies of angiogenesis factors]N Ortéga, F Jonca, S Vincent, et al.
ISRN Endocrinology|October 12, 2012
The global transcriptional response of isolated human islets of langerhans to glucagon-like Peptide-1 receptor agonist liraglutideXiaoning Zhao, Yongming G Tang, S Vincent Wu, et al.
Pageof 120

Showing results (681-690 of 1,192) with videos related to

Sort By:
Pageof 120
European Journal of Haematology|November 11, 2014
Clinical course and prognosis of non-secretory multiple myelomaSagar S Chawla, Shaji K Kumar, Angela Dispenzieri, et al.
The American Journal of Tropical Medicine and Hygiene|August 9, 2019
Use of a Blockade-of-Binding ELISA and Microneutralization Assay to Evaluate Zika Virus Serostatus in Dengue-Endemic AreasEduardo J M Nascimento, Matthew I Bonaparte, Ping Luo, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|May 11, 2004
Characterization of the rat intestinal Fc receptor (FcRn) promoter: transcriptional regulation of FcRn gene by the Sp family of transcription factorsLingling Jiang, Jiafang Wang, R Sergio Solorzano-Vargas, et al.
Mayo Clinic Proceedings|August 4, 2009
Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patientsJohn P Bida, Robert A Kyle, Terry M Therneau, et al.
Blood Cancer Journal|June 11, 2024
Performance of newer myeloma staging systems in a contemporary, large patient cohortGhulam Rehman Mohyuddin, Samuel M Rubinstein, Shaji Kumar, et al.
The Lancet. Oncology|October 27, 2009
Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trialS Vincent Rajkumar, Susanna Jacobus, Natalie S Callander, et al.
British Journal of Haematology|December 5, 2009
Impact of dexamethasone responsiveness on long term outcome in patients with newly diagnosed multiple myelomaShirshendu Sinha, S Vincent Rajkumar, Martha Q Lacy, et al.
The Clinical Neuropsychologist|January 25, 2012
Cognitive change associated with self-reported mild traumatic brain injury sustained during the OEF/OIF conflictsTresa M Roebuck-Spencer, Andrea S Vincent, David A Twillie, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|May 1, 1996
[Modulation of the tumoral progression by anti-idiotypic antibodies of angiogenesis factors]N Ortéga, F Jonca, S Vincent, et al.
ISRN Endocrinology|October 12, 2012
The global transcriptional response of isolated human islets of langerhans to glucagon-like Peptide-1 receptor agonist liraglutideXiaoning Zhao, Yongming G Tang, S Vincent Wu, et al.
Pageof 120